Sunshine Biopharma Inc.
SBFM· Nasdaq
Filed Aug 6, 2015 · 10-Q · 37 days after period end · 0001354488-15-003598
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $1.71K | $0.00 | $0.00 | $0.00 |
| Net Income | -$517.51K | -$765.51K | -$152.97K | -$103.07K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 6, 2015 · 37 d after period end